© Copyright 2025 American Medical Association. All rights reserved.
Short Descr | SARSCOV2 VAC BVL 3MCG/0.2ML | Medium Descr | SARSCOV2 VACCINE BIVALENT 3 MCG/0.2 ML IM USE | Long Descr | Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Influenza, Pneumococcal Pneumonia, Hepatitis B, and Covid-19 Vaccines; Monoclonal Antibody Therapy Product | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
Date
|
Action
|
Notes
|
---|---|---|
2025-01-01 | Deleted | First appearance of code deletion in codebook. |
2024-01-01 | Added | First appearance in codebook. |
2023-11-01 | Deleted | Code deleted. See 91318, 91319, 91320, 91321, 91322. |
2023-04-18 | Note | AMA guidelines changed to include 0121A, 0151A, 0171A, 0172A. Published to website 2023-05-01. Received FDA approval effective retroactively to 2023-04-18. |
2023-04-18 | Note | These codes (included in the guidelines) are no longer authorized for use in the United States: 0001A, 0002A, 0003A, 0004A, 0051A, 0052A, 0053A, 0054A, 0071A, 0072A, 0073A, 0074A, 0081A, 0082A, 0083A, 91308. |
2023-04-18 | Note | Changes made to dosing information. |
2023-03-17 | Note | New AMA guideline added. |
2023-03-14 | Note | AMA guideline changed to include 0174A. Published to website 2023-03-17. Received FDA approval effective retroactively to 2023-03-14. |
2022-12-08 | Added | Published on AMA website December 9, FDA approval received retroactively, effective 2022-12-08. |
2022-12-08 | Note | AMA guideline changed to include 0173A. Published to website 2022-12-09. Received FDA approval effective retroactively to 2022-12-08. |
2022-12-08 | Note | AMA guideline codes 0001A, 0002A, 0003A, 0004A, 0051A, 0052A, 0053A, 0054A, 0071A, 0072A, 0073A, 0074A, 0081A, 0082A, 0083A, 0124A, 0154A, 91308 added to website & received FDA approval prior to the addition of 91317. |
Get instant expert-level medical coding assistance.